Cargando…
Combinatorial drug screening identifies compensatory pathway interactions and adaptive resistance mechanisms
Constitutively activated signaling molecules are often the primary drivers of malignancy, and are favored targets for therapeutic intervention. However, the effectiveness of targeted inhibition of cell signaling can be blunted by compensatory signaling which generates adaptive resistance mechanisms...
Autores principales: | Axelrod, Mark, Gordon, Vicki L., Conaway, Mark, Tarcsafalvi, Adel, Neitzke, Daniel J., Gioeli, Daniel, Weber, Michael J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3720609/ https://www.ncbi.nlm.nih.gov/pubmed/23599172 |
Ejemplares similares
-
Combinatorial drug screening and molecular profiling reveal diverse mechanisms of intrinsic and adaptive resistance to BRAF inhibition in V600E BRAF mutant melanomas
por: Roller, Devin G., et al.
Publicado: (2015) -
Identification of Kinases Regulating Prostate Cancer Cell Growth Using an RNAi Phenotypic Screen
por: Whitworth, Hilary, et al.
Publicado: (2012) -
Combinatorial drug screening identifies synergistic co-targeting of Bruton's tyrosine kinase and the proteasome in mantle cell lymphoma
por: Axelrod, M, et al.
Publicado: (2014) -
Systems Analysis of Adaptive Responses to MAP Kinase Pathway Blockade in BRAF Mutant Melanoma
por: Capaldo, Brian J., et al.
Publicado: (2015) -
Minimized combinatorial CRISPR screens identify genetic interactions in autophagy
por: Diehl, Valentina, et al.
Publicado: (2021)